Barclays share price to benefit as Q3 M&A deals top $1 trillion
Barclays share price has jumped in the past few months and is hovering at its highest point since 2007. It...
Barclays share price has jumped in the past few months and is hovering at its highest point since 2007. It...
Coty Inc. has begun a strategic review of its mass-market beauty business, which houses drugstore staples including CoverGirl, Sally Hansen,...
It is a financial juggernaut operating on a scale that defies belief, a money-making and money-burning machine at the very...
The surprising strength that characterized the start of September has given way to a palpable sense of fear, as a...
Jerry Greenfield, co-founder of the Ben & Jerry’s ice cream brand, has stepped down from the company he started 47...
President Donald Trump on Thursday announced a new round of punishing tariffs, saying the United States will impose a 100%...
Toyota Motor Corp reported Monday that its global vehicle sales rose for an eighth consecutive month in August, supported by...
Denmark’s Genmab has agreed to acquire Merus NV, a Nasdaq-listed Dutch biotechnology company, in an all-cash transaction valued at $8...
European shares edged higher on Monday, lifted by gains in healthcare and technology, as investors weighed the risk of a...
GSK announced on Monday that Chief Executive Emma Walmsley will step down after nine years in the role, with current...
Disclaimer: EarningsMastery.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.